China Regenerative Medicine International Ltd 08158
Trading Information
- Previous Close Price
- HK$0.32
- Day Range
- HK$0.32–0.32
- 52-Week Range
- HK$0.00–0.69
- Bid/Ask
- HK$0.00 / HK$0.30
- Shares Outstanding
- 304.25M
- Market Cap
- HK$91.28M
- Volume/Avg
- 125,000 / 73,063
Key Statistics
- Price/Earnings (Normalized)
- 3.31
- Price/Sales
- 1.06
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
China Regenerative Medicine International Ltd is an investment holding company. The company is engaged in the provision of healthcare products and services. It is engaged in research and development, production and sales of tissue engineering and regenerative medicine products. The business scope of company includes tissue engineering, cosmetics, cell storage, preparation and therapy, hospitals administration and other business division. The segments of the company are Aesthetic medical and beauty services and Medical services. The majority of the company's revenue is derived from its Aesthetic medical and beauty services segment that provides medical beauty products and services. Geographically, the Hong Kong accounts for the majority of the revenue and also has a presence in PRC.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 33
- Website
- https://www.crmi.hk
Valuation
|
Metric
|
08158
|
|---|---|
Price/Earnings (Normalized) | 3.31 |
Price/Book Value | 1.61 |
Price/Sales | 1.06 |
Price/Cash Flow | 5.84 |
Price/Earnings
08158
Financial Strength
|
Metric
|
08158
|
|---|---|
Quick Ratio | 1.22 |
Current Ratio | 1.57 |
Interest Coverage | 4.32 |
Quick Ratio
08158
Profitability
|
Metric
|
08158
|
|---|---|
Return on Assets (Normalized) | 17.61% |
Return on Equity (Normalized) | 83.72% |
Return on Invested Capital (Normalized) | 18.98% |
Return on Assets
08158
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|$!>z>q% | LOCK|j@W< | $127B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|%X%#Pfw | LOCK|^t%> | $76B | |||
| Moderna Inc
MRNA
| LOCK|j%@$!M | LOCK|<J< | $75B | |||
| argenx SE ADR
ARGX
| LOCK|!W%>h#L | LOCK|&y | $59B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|?>rk!<$ | LOCK|&H# | $43B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|j@?VJ@< | LOCK|S@m! | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|YN#M<pqD | LOCK|W&Pz | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|$$&V#m | LOCK|qV? | $24B | |||
| Incyte Corp
INCY
| LOCK|%Vv#rBY | LOCK|&r | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|fQ<!#nY | LOCK|$^h | $15B |
United States